Brain tumors are masses of abnormally proliferating cells arising from the brain or its coverings. They fall into two broad categories: primary brain tumors and metastatic brain tumors (tumors that have spread from elsewhere in the body).
Overview
Primary brain tumors may arise from glial cells (astrocytes, oligodendrocytes and ependymal cells), from neuronal cells, from meningeal cells or from Schwann cells.
Most primary brain tumors, notably astrocytomas, are graded according to the four-tier system of the World Health Organization (WHO), ranging from grade 1 to grade 4.
Why brain tumors develop remains unclear. Despite numerous large epidemiological studies, no specific risk factor has been identified for most brain tumors. The risk increases with age, and prior therapeutic radiation has been shown to increase the risk of glioma and meningioma.
Metastatic tumors are the most frequently encountered group of brain tumors. All metastatic tumors are regarded as malignant. Their behavior varies considerably with the type of primary tumor. In order of frequency, the tumors that most commonly metastasize to the brain are:
- lung cancer;
- breast cancer;
- renal cell carcinoma;
- melanoma;
- colon cancer.
Types of Brain Tumors
There are many types of central nervous system tumors; some of the more common ones are described below.
Astrocytoma
Astrocytomas arise from astrocytes, the star-shaped glial cells that support the central nervous system. They are divided into grades according to their histological features; the grade is determined by a pathologist who examines the tissue under the microscope. Low-grade astrocytomas account for 15% of primary brain tumors and tend to present in patients in their thirties and forties. Surgery is the primary treatment whenever possible, with chemotherapy and radiotherapy when required.
Glioblastoma
Glioblastoma (formerly called glioblastoma multiforme) is the most common and most malignant astrocytic tumor (WHO grade 4). It accounts for 25% of primary brain tumors and is most frequently diagnosed in patients aged 55 to 75. Standard treatment is radiotherapy combined with chemotherapy following resection or biopsy.
Oligodendroglioma
These tumors arise from oligodendrocytes, the cells that produce myelin (the insulating sheath around nerve fibers) within the central nervous system. Oligodendrogliomas account for 15–20% of primary brain tumors. They carry a better prognosis than astrocytomas. Oligodendrogliomas with 1p/19q codeletion tend to respond better to treatment (radiotherapy or chemotherapy) and to follow a more favorable course irrespective of treatment.
Ependymoma
Ependymomas arise from the ependymal cells lining the cerebrospinal fluid spaces. They occur in both children and adults and account for 2.5% of brain tumors in adults. Standard treatment is surgery combined with radiotherapy and/or chemotherapy.
Meningioma
Meningiomas arise from arachnoid cap cells in the arachnoid, one of the membranes covering the brain and spinal cord. They account for 20–25% of primary brain tumors and their incidence rises with age. The great majority are benign and can be treated by surgical resection. Radiosurgery is also an effective treatment option for meningioma. For high-grade meningiomas, chemotherapy and other medical treatments are further options.
Epidermoid and Dermoid Tumors
Epidermoids are benign, keratin-forming lesions usually located in the posterior fossa. Dermoid tumors tend to lie in the midline of the central nervous system and may contain tissues such as hair, sweat glands and sebaceous glands. Both may be treated surgically.
Schwannoma
Schwannomas arise from Schwann cells, which produce the myelin sheath of peripheral nerves. They account for 8–10% of primary brain tumors. The most common sites are the eighth cranial nerve (vestibular schwannoma) and the fifth cranial nerve. These tumors are usually benign and can be treated by surgical excision. Small schwannomas may be treated successfully with radiosurgery.
Symptoms
The symptoms of a brain tumor vary with the region in which the lesion lies. The following may be observed:
- headache;
- seizures;
- speech difficulties;
- altered consciousness;
- weakness or numbness in part of the body;
- cranial nerve dysfunction (for example, impaired hearing, vision or swallowing).
The symptoms also depend on how fast the tumor grows and are usually progressive.
Diagnosis
A brain tumor is usually diagnosed with magnetic resonance imaging (MRI) with and without contrast. Computed tomography (CT) and digital subtraction angiography may be used in addition when required.
Treatment
The treatment options for a brain tumor are surgery, radiotherapy and chemotherapy. Depending on the patient and the pathology, one of these may be used alone or several in combination.
During surgery, an incision is made in the scalp, a section of the bone overlying the tumor is temporarily removed (craniotomy) and the tumor is excised under the microscope. Patients usually remain in the hospital for three to four days after surgery.
In tumors such as astrocytoma, glioblastoma, oligodendroglioma, ependymoma and medulloblastoma, microscopic disease persists even after the tumor has been removed because of their infiltrative nature.
Radiosurgery is a further option for lesions such as meningioma, schwannoma, craniopharyngioma, pituitary tumors and metastatic tumors. Using a stereotactic frame, radiation is delivered precisely to the target while healthy brain tissue is spared.
Follow-up
All patients treated for a brain tumor require long-term, close follow-up with neurological examination and imaging, both to assess the effectiveness of treatment and to detect recurrence.